Mount Sinai—National Jewish Health Respiratory Institute Host IPF Meetings

The Mount Sinai – National Jewish Health Respiratory Institute will host the successful education program “Best Practices in Caring for Patients with Idiopathic Pulmonary Fibrosis” in the greater New York City area. The four free continuing medical education (CME) dinner meetings will take place at venues in New York and New Jersey in late February and early March. This program is part of the successful education program developed by National Jewish Health and previously presented in other parts of the country.

“Idiopathic Pulmonary Fibrosis (IPF) is a devastating disease that requires a dedicated, multidisciplinary evaluation to accurately diagnose and care for patients,” said Gregory Cosgrove, MD, FCCP. “Through enhanced awareness and collaboration with the Mount Sinai — National Jewish Health Respiratory Institute, we aim to educate, support, and improve the lives of patients everywhere with IPF.” Dr. Cosgrove is an associate professor in the Department of Medicine, Division of Pulmonary and Critical Care Medicine at National Jewish Health and on staff at the Mount Sinai – National Jewish Health Respiratory Institute. He is also chair of the project and a speaker at the event.

“We are excited to bring this program to our physician community in the New York area. It is an example of the kinds of high quality programs we are providing through the collaborative approach of the Respiratory Institute,” said Charles Powell, M.D., Chief of Pulmonary, Critical Care, and Sleep Medicine at Icahn School of Medicine at Mount Sinai, and CEO of the Respiratory Institute.

The certified educational program addresses gaps in the diagnosis and treatment of patients with IPF. The meetings are designed for family practice and internal medicine physicians, community pulmonologists who treat IPF, physician assistants, advanced practice nurses, registered nurses and respiratory therapists.

Also presenting at the New York area events will be Maria Padilla, MD, Professor of Medicine, Pulmonary, Critical Care and Sleep Medicine Division, Icahn School of Medicine at Mount Sinai - National Jewish Health Respiratory Institute, and Joshua Solomon, MD, Assistant Professor, Department of Medicine, Division of Pulmonary and Critical Care Medicine, National Jewish Health.

“These meetings are so successful because they bring together great doctors with a desire to deliver excellent care with doctors who have a wealth of knowledge acquired over many years of working with IPF patients,” said Dr. Solomon. “This meeting of minds brings great benefit to both groups and, in the end, improves the care of patients with this devastating disease.”

Prognosis for IPF is frequently poor despite recent, significant advances, including new evidence-based guidelines for diagnosis and treatment. Meeting participants will gain knowledge to improve competence and performance in diagnosis, management and treatment of patients with IPF at an evening symposium that incorporates case-based learning, multi-media approaches and written materials. Information also will be presented about the first two therapies recently approved by the U.S. Food and Drug Administration for the treatment of patients with IPF.

This activity is supported by independent educational grants from Boehringer Ingelheim Pharmaceuticals, Inc. and InterMune, Inc. Health care professionals will have four opportunities to attend:

• New York, NY, on Tuesday, February 24, 2015
• Tarrytown, NY on Wednesday, February 25, 2015
• Newark, NJ, on Wednesday, March 4, 2015
• Woodbury, NY, on Thursday, March 5, 2015.

For more information and to secure a spot at one of the upcoming meetings, please call the Office of Professional Education at National Jewish Health at 800.844.2305.

The Mount Sinai – National Jewish Health Respiratory Institute is a partnership between the Icahn School of Medicine at Mount Sinai, a top-ranked academic medical center in New York City, and National Jewish Health, the nation’s leading respiratory hospital based in Denver, Colorado. Combining the strengths of both entities into an integrated Respiratory Institute brings together leading expertise in diagnosing and treating all forms of respiratory illness and lung disease, including asthma, chronic obstructive pulmonary disease (COPD), interstitial lung disease (ILD) and bronchiectasis. The Respiratory Institute creates new options for care for patients in New York City and the surrounding region. Learn more about The Respiratory Institue.